September 22, 2019  |  

Differential TGFß pathway targeting by miR-122 in humans and mice affects liver cancer metastasis.

Authors: Yin, Shenyi and Fan, Yu and Zhang, Hanshuo and Zhao, Zhihua and Hao, Yang and Li, Juan and Sun, Changhong and Yang, Junyu and Yang, Zhenjun and Yang, Xiao and Lu, Jian and Xi, Jianzhong Jeff

Downregulation of a predominantly hepatocyte-specific miR-122 is associated with human liver cancer metastasis, whereas miR-122-deficient mice display normal liver function. Here we show a functional conservation of miR-122 in the TGFß pathway: miR-122 target site is present in the mouse but not human TGFßR1, whereas a noncanonical target site is present in the TGFß1 5'UTR in humans and other primates. Experimental switch of the miR-122 target between the receptor TGFßR1 and the ligand TGFß1 changes the metastatic properties of mouse and human liver cancer cells. High expression of TGFß1 in human primary liver tumours is associated with poor survival. We identify over 50 other miRNAs orthogonally targeting ligand/receptor pairs in humans and mice, suggesting that these are evolutionarily common events. These results reveal an evolutionary mechanism for miRNA-mediated gene regulation underlying species-specific physiological or pathological phenotype and provide a potentially valuable strategy for treating liver-associated diseases.

Journal: Nature communications
DOI: 10.1038/ncomms11012
Year: 2016

Read publication

Talk with an expert

If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.